Biotechs Turn to M&A as Liquidity Surges and Market Caps Falter

Submitted by admin on April 25, 2022 - 10:44am

Source:

BioSpace

News Tags:

Headline:

snippet:

The 20 largest companies on the NBI had an average return of 27.6%.
Small-cap biotechs’ stock prices dropped 17% and mid-cap stocks dropped 7%. (Year-to-date, the Nasdaq Biotech Index (NBI) has declined more than 10%.
20% of companies on the NBI saw their market capitalization fall below $ 200 million – the threshold to be listed on that index.

Search form